Call Options Transactions Made in Q2 2023 in Arbutus Biopharma Corp (ABUS)
This table provides information about the institutional ownership of Arbutus Biopharma Corp (ABUS) during Q2 2023. The information is specifically focused on institutions that hold call options of Arbutus Biopharma Corp.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 10, 2023
Q2 2023
|
Citigroup Inc
|
BUY
|
CALL |
94.4K+ 51.44% |
$211K - $289K
|
278K
$1.09M
|
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-55.8K- 33.76% |
$125K - $171K
|
110K
$431K
|
|
|
Aug 11, 2023
Q2 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
CALL |
-232K- 68.27% |
$521K - $711K
|
108K
$426K
|